CASTLE BIOSCIENCES, INC.
Revenue Breakdown
| Fiscal Year | DecisionDx-Melanoma | DecisionDx-SCC | DecisionDx-UM | Other dermatological | TissueCypher | IDgenetix |
|---|---|---|---|---|---|---|
| FY2022 | $97.5M | $24.2M | $7.4M | $4.1M | $3.8M | $785.0K |
| FY2023 | $137.7M | $29.0M | $7.9M | $4.5M | $28.5M | $12.2M |
Revenue Breakdown
| Fiscal Year | DecisionDx-Melanoma | DecisionDx-SCC | DecisionDx-UM | Other dermatological | TissueCypher | IDgenetix |
|---|---|---|---|---|---|---|
| FY2022 | $97.5M | $24.2M | $7.4M | $4.1M | $3.8M | $785.0K |
| FY2023 | $137.7M | $29.0M | $7.9M | $4.5M | $28.5M | $12.2M |